Leishmaniasis treatment: update of possibilities for drug repurposing

VV Andrade Neto, EF Cunha Junior, VS Faioes… - 2018 - arca.fiocruz.br
The leishmaniases represent a public health problem in under-developed countries and are
considered a neglected disease by the World Health Organization (WHO). They are cuased …

[HTML][HTML] Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target Against Trypanosoma cruzi

G Benaim, AE Paniz-Mondolfi, EM Sordillo… - Frontiers in cellular …, 2020 - frontiersin.org
There is no effective cure for Chagas disease, which is caused by infection with the
arthropod-borne parasite, Trypanosoma cruzi. In the search for new drugs to treat Chagas …

[HTML][HTML] Recent advances in chemotherapeutics for leishmaniasis: Importance of the cellular biochemistry of the parasite and its molecular interaction with the host

R Singh, M Kashif, P Srivastava, PP Manna - Pathogens, 2023 - mdpi.com
Leishmaniasis, a category 1 neglected protozoan disease caused by a kinetoplastid
pathogen called Leishmania, is transmitted through dipteran insect vectors (phlebotomine …

[HTML][HTML] The antimicrobial activity of innate host-directed therapies–a systematic review

T Shapira, M Christofferson, Y Av-Gay - International Journal of …, 2024 - Elsevier
Intracellular human pathogens are the deadliest infectious diseases and pose great difficulty
to effectively treat due to their protection inside the host cell and the development of …

SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca2+ homeostasis, collapsing the mitochondrial electrochemical potential (ΔΨm) …

Z Gil, N Martinez-Sotillo, A Pinto-Martinez, F Mejias… - Parasitology …, 2020 - Springer
Leishmania donovani is the causative agent of visceral leishmaniasis. Annually, 500 million
new cases of infection are reported mainly in poor communities, decreasing the interest of …

The role of Ca2+ in the process of cell invasion by intracellular parasites

R Docampo, SNJ Moreno - Parasitology Today, 1996 - cell.com
In order to replicate, many parasites must invade host cells. Changes in the intracelhdar Ca
2ũ concentration ([Ca~-*]) of different parasites and tissue culttnv cells during their …

Screening of novel inhibitors against Leishmania donovani calcium ion channel to fight leishmaniasis

M Kashif, PP Manna, Y Akhter… - … Current Drug Targets …, 2017 - ingentaconnect.com
Leishmania is an intracellular protozoan parasite which causes Leishmaniasis, a global
health problem affecting millions of people throughout 89 different countries in the world …

Neglected tropical protozoan diseases: drug repositioning as a rational option

M Laura Sbaraglini, M Cristina Vanrell… - Current topics in …, 2016 - ingentaconnect.com
Neglected tropical diseases represent a major sanitary problem and a huge economic
burden to endemic countries, and are currently expanding to non-endemic countries owing …

In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR

JQ Reimão, FA Colombo, VL Pereira-Chioccola… - Experimental …, 2011 - Elsevier
The need for novel and efficacious drugs against neglected parasitic diseases, such as
Leishmaniasis and American Trypanosomiasis, is certainly apparent. In this work, we …

Chagas disease: drug development and parasite targets

AB Vermelho, V Cardoso, FRP Mansoldo… - … Drug Development and …, 2022 - Springer
Chagas disease (CD) is a neglected disease that is endemic to Central and South America
and is caused by the protozoan parasite Trypanosoma cruzi. The discovery of new drugs …